These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2. Verteporfin In Photodynamic Therapy Study Group Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389 [TBL] [Abstract][Full Text] [Related]
4. [Submacular hemorrhage following photodynamic therapy in the treatment of choroidal neovascularization]. Díaz-de-Durana-Santa-Coloma E; Fernández-Ares ML; Iturralde-Errea D; Salazar-Díez JL; Vázquez-Cruchaga E; López-Garrido JA Arch Soc Esp Oftalmol; 2006 Dec; 81(12):685-91. PubMed ID: 17199162 [TBL] [Abstract][Full Text] [Related]
5. Triamcinolone and PDT to treat exudative age-related macular degeneration and submacular hemorrhage. Ruiz-Moreno JM; Montero JA; Barile S Eur J Ophthalmol; 2006; 16(3):426-34. PubMed ID: 16761245 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441 [TBL] [Abstract][Full Text] [Related]
7. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration. Voelker M; Gelisken F; Ziemssen F; Wachtlin J; Grisanti S Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1241-6. PubMed ID: 16010552 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy. Ladd BS; Solomon SD; Bressler NM; Bressler SB Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027 [TBL] [Abstract][Full Text] [Related]
9. Can intravitreal tissue plasminogen activator and SF6 gas facilitate management of macular degeneration with photodynamic therapy? Muqit MM; Ghanchi FD Eur J Ophthalmol; 2008; 18(4):591-4. PubMed ID: 18609480 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital. Essex RW; Qureshi SH; Cain MS; Harper CA; Guymer RH Clin Exp Ophthalmol; 2003 Dec; 31(6):476-81. PubMed ID: 14641153 [TBL] [Abstract][Full Text] [Related]
11. Limited macular translocation compared with photodynamic therapy in the management of subfoveal choroidal neovascularization in age-related macular degeneration. Pawlak D; Glacet-Bernard A; Papp M; Roquet W; Coscas G; Soubrane G Am J Ophthalmol; 2004 May; 137(5):880-7. PubMed ID: 15126153 [TBL] [Abstract][Full Text] [Related]
12. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Spaide RF; Sorenson J; Maranan L Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166 [TBL] [Abstract][Full Text] [Related]
13. Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin. Ophthalmology; ; . PubMed ID: 16214216 [TBL] [Abstract][Full Text] [Related]